330 related articles for article (PubMed ID: 37795365)
1. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer.
Ye Z; Yang J; Jiang H; Zhan X
Front Endocrinol (Lausanne); 2023; 14():1220108. PubMed ID: 37795365
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
3. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
[TBL] [Abstract][Full Text] [Related]
5. Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation.
Gross PH; Sheets KJ; Warren NA; Ghosh S; Varghese RE; Wass KWass KE; Kadimisetty K
Biochem Biophys Res Commun; 2022 Nov; 628():68-75. PubMed ID: 36084553
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway.
Lu M; Liu T; Jiao Q; Ji J; Tao M; Liu Y; You Q; Jiang Z
Eur J Med Chem; 2018 Feb; 146():251-259. PubMed ID: 29407955
[TBL] [Abstract][Full Text] [Related]
7. Tools to investigate the ubiquitin proteasome system.
Leestemaker Y; Ovaa H
Drug Discov Today Technol; 2017 Dec; 26():25-31. PubMed ID: 29249239
[TBL] [Abstract][Full Text] [Related]
8. The role of allostery in the ubiquitin-proteasome system.
Liu J; Nussinov R
Crit Rev Biochem Mol Biol; 2013; 48(2):89-97. PubMed ID: 23234564
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
10. Targeted Protein Degradation: Principles and Applications of the Proteasome.
Kim Y; Kim EK; Chey Y; Song MJ; Jang HH
Cells; 2023 Jul; 12(14):. PubMed ID: 37508510
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics.
Zhan X; Lu M; Yang L; Yang J; Zhan X; Zheng S; Guo Y; Li B; Wen S; Li J; Li N
Front Endocrinol (Lausanne); 2022; 13():970843. PubMed ID: 36187110
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in PROTACs for Drug Targeted Protein Research.
Yao T; Xiao H; Wang H; Xu X
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142231
[TBL] [Abstract][Full Text] [Related]
13. Proteasome substrate receptors and their therapeutic potential.
Osei-Amponsa V; Walters KJ
Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
[TBL] [Abstract][Full Text] [Related]
14. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
15. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
Collins I; Wang H; Caldwell JJ; Chopra R
Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
[TBL] [Abstract][Full Text] [Related]
16. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
Guharoy M; Bhowmick P; Tompa P
J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
[TBL] [Abstract][Full Text] [Related]
17. Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders.
Diehl CJ; Ciulli A
Chem Soc Rev; 2022 Oct; 51(19):8216-8257. PubMed ID: 35983982
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.
de Bie P; Ciechanover A
Cell Death Differ; 2011 Sep; 18(9):1393-402. PubMed ID: 21372847
[TBL] [Abstract][Full Text] [Related]
19. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
